| An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye D Jaishankar, AM Yakoub, T Yadavalli, A Agelidis, N Thakkar, S Hadigal, ... Science translational medicine 10 (428), eaan5861, 2018 | 81 | 2018 |
| Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery T Yadavalli, J Ames, A Agelidis, R Suryawanshi, D Jaishankar, J Hopkins, ... Science advances 5 (8), eaax0780, 2019 | 60 | 2019 |
| Targeting herpes simplex virus-1 gD by a DNA aptamer can be an effective new strategy to curb viral infection T Yadavalli, A Agelidis, D Jaishankar, K Mangano, N Thakkar, ... Molecular Therapy-Nucleic Acids 9, 365-378, 2017 | 54 | 2017 |
| Emerging roles of heparanase in viral pathogenesis N Thakkar, T Yadavalli, D Jaishankar, D Shukla Pathogens 6 (3), 43, 2017 | 50 | 2017 |
| Cultured corneas show dendritic spread and restrict herpes simplex virus infection that is not observed with cultured corneal cells N Thakkar, D Jaishankar, A Agelidis, T Yadavalli, K Mangano, S Patel, ... Scientific reports 7 (1), 42559, 2017 | 15 | 2017 |
| Dual role for autophagy in herpes simplex virus infection of the cornea D Shukla, N Thakkar, D Jaishankar Investigative Ophthalmology & Visual Science 58 (8), 3619-3619, 2017 | | 2017 |
| Antiviral activity of a 45 nucleotide DNA aptamer during HSV-1 infection of the cornea. T Yadavalli, N Thakkar, D Jaishankar, A Agelidis, D Shukla Investigative Ophthalmology & Visual Science 58 (8), 3599-3599, 2017 | | 2017 |
